[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 9, Issue 1 (1-2018) ::
Caspian J Intern Med 2018, 9(1): 60-64 Back to browse issues page
Fecal calprotectin Level in patients with IBD and noninflammatory disease of colon: a study in Babol, Northern, Iran
Majid Sharbatdaran, Amin Halakou, Mehrdad Kashifard, Ali Bijani, Alireza Firozjaei, Akram Hossaini, Sepideh Siadati
Cancer Research Center, Health Research Institute, Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran , bcrdc90@yahoo.com
Abstract:   (3438 Views)
Background: Inflammatory bowel disease (IBD) is a chronic disease with a relapsing course of inflammation in the digestive system. Endoscopy and histopathology are the golden standard methods for detection and assessment of IBD. A distinct increase of fecal calprotectin level can be a useful marker for the diagnosis of IBD. The aim of this study was to evaluate the fecal calprotectin level in patients with IBD and without inflammatory diseases of the colon.
Methods: Calprotectin levels of patients referred to the Ayatollah Rouhani Hospital of Babol, northern Iran with clinical symptoms of colon disease were evaluated. After a week, colonoscopy and biopsy were performed on all patients and they were divided into two groups. The first group included patients with confirmed IBD and the second group included patients with diseases other than IBD, patients with IBS and healthy persons. Then the measured fecal calprotectin level was compared between the two groups before colonoscopy.
Results: We observed correlation between calprotection in these two groups (p<0.0001). 38 (86.8%) patients in the case group and 5 (13.2%) patients in the control group had positive fecal calprotectin test and 12 (23.1%) patients in the case group and 40 (76.9%) patients in the control group had negative results. Basad on ROC curve, the cutoff point of calprotectin was 127.65 with 73% sensitivity and 89% specificity. The area under the curve was 0.83 with 95% confidence interval, 0.74-0.91 (p<0.0001).
Conclusions: The results pointed to this fact that fecal calprotectin can be a noninvasive marker in differentiating IBD from IBS

Keywords: Fecal calprotectin level, Inflammatory bowel disease, Irritable bowel syndrome
Full-Text [PDF 333 kb]   (588 Downloads)    
Type of Study: Original Article | Subject: Pathology
Received: 2015/04/22 | Accepted: 2017/08/12 | Published: 2017/10/18
Send email to the article author

Add your comments about this article
Your username or Email:


XML     Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Sharbatdaran M, Halakou A, Kashifard M, Bijani A, Firozjaei A, Hossaini A et al . Fecal calprotectin Level in patients with IBD and noninflammatory disease of colon: a study in Babol, Northern, Iran. Caspian J Intern Med. 2018; 9 (1) :60-64
URL: http://caspjim.com/article-1-524-en.html

Volume 9, Issue 1 (1-2018) Back to browse issues page
Caspian Journal of Internal Medicine
Persian site map - English site map - Created in 0.06 seconds with 32 queries by YEKTAWEB 4102